Clinical Trials Sponsored by Benjamin U. Nwosu, MD
Total 1 results
-
Benjamin U. Nwosu, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
Sponsors and Collaborators
- Donders Institute for Brain, Cognition and Behavior
- Victor Montori
- Diego Hernan Giunta, MD
- Societa Italiana di Endoscopia Digestiva
- Caritas Freetown
- Cardresearch
- CRMBM-CEMEREM
- University Medical Center Goettingen
- Elim Pediatric Pharmaceuticals Inc.
- Rui-hua Xu, MD, PhD
- Norsk Proteinintolerance, Norway
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- ProteoSys AG
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- AMTC & Associates
- The Fifth Affiliated Hospital of Zunyi Medical College
- San MediTech(Huzhou)Co.,Ltd.
- Alberta Children's Hospital, Calgary, Canada
- Celtaxsys Aus Pty Limited
- Fondren Orthopedic Group L.L.P.
- View Full List
Medical Conditions
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Non-dystrophic Myotonias
- Postcomatose Unawareness State
- Normal Diameter of Optic Nerve
- Lymphedema of Arm
- Stereotactic Radioablation for Ventricular Tachycardia
- Auditory Hallucination, Verbal
- Tularaemia
- Atrial Fibrillation, Postoperative
- Prostate Cancer Recurrent
- Spermatogenesis Arrest
- Orbital Tumor
- Malignant Ascites Due to Epithelial Carcinoma
- Gynecologic Cancer
- Fever, Sweats, and Hot Flashes
- Non-compressible Torso Hemorrhage
- Tube Disorders Eustachian
- Plasmodium Falciparum Malaria (Drug Resistant)
- Fibromyalgia Syndrome, Primary
- Disturbance of Activity and Attention
- View Full List
Drug Interventions
- Mupirocin Calcium
- Methotrexate
- Bortezomib/dexamethasone
- Flibanserin 100 mg dose every evening
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Insulin
- Topotecan
- PF-00868554
- Polyethylene glycol 3350
- Indoximod
- Epimedium Prenylflavonoids Extract
- Oxycodone, fentanyl
- Atezolizumab
- SERETIDE Diskus
- Cytarabine ARA-C
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Cetrorelix 78 mg + 78 mg
- Enzalutamide, Abiraterone
- Lamivudine
- Ruxolitinib
- View Full List
CROs by country
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in France
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Japan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Norway
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Senegal
- Contract Research Organizations in Slovenia
- CRO list by country